Recommended public cash offer of Amgen Inc. to the shareholders of Nuevolution AB (publ)

English | Svenska

Documents

Offer document

Acceptance form – corporate entities

Acceptance form – individuals

Press Releases

26 JULY 2019: AMGEN CONTROLS 98% OF THE SHARES IN NUEVOLUTION AFTER THE END OF THE EXTENDED ACCEPTANCE PERIOD

8 JULY 2019: AMGEN ANNOUNCES THE OUTCOME OF THE RECOMMENDED PUBLIC CASH OFFER TO THE SHAREHOLDERS OF NUEVOLUTION, DECLARES THE OFFER UNCONDITIONAL AND COMPLETES THE OFFER

12 JUNE 2019: AMGEN PUBLISHES OFFER DOCUMENT WITH RESPECT TO THE RECOMMENDED PUBLIC CASH OFFER TO THE SHAREHOLDERS OF NUEVOLUTION

28 MAY 2019: ADDITIONAL IRREVOCABLE UNDERTAKINGS TO ACCEPT AMGEN’S RECOMMENDED PUBLIC CASH OFFER TO THE SHAREHOLDERS OF NUEVOLUTION

21 MAY 2019: AMGEN ANNOUNCES A RECOMMENDED PUBLIC CASH OFFER TO THE SHAREHOLDERS OF NUEVOLUTION

For further information, please contact:

Investors: Arvind Sood, +1 805-447-1060
Media: Trish Hawkins, +1 805-447-5631


Terms of Use Privacy Statement